Unnamed: 0,title,date,stock,sentiment
542789.0,"Shares of several healthcare companies are trading higher on continued optimism amid the reopening of the economy, which would increase consumer spending and economic activity.",2020-06-08 11:41:00-04:00,GERN,positive
542790.0,Geron 13D Filing From Growth Equity Opportunities 17 Shows 9.6% Stake,2020-06-04 15:06:00-04:00,GERN,positive
542791.0,"Cantor Fitzgerald Maintains Overweight on Geron, Raises Price Target to $4",2020-06-01 07:13:00-04:00,GERN,negative
542792.0,Geron shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.,2020-05-29 08:48:00-04:00,GERN,positive
542793.0,"B. Riley FBR Maintains Buy on Geron, Raises Price Target to $4",2020-05-29 08:13:00-04:00,GERN,neutral
542794.0,"Geron Q1 EPS $(0.08) Beats $(0.12) Estimate, Sales $52.00K Beat $50.00K Estimate",2020-05-28 16:10:00-04:00,GERN,neutral
542795.0,"The Daily Biotech Pulse: PhaseBio To Start Potential Pivotal COVID-19 Trial, Immunomedics CEO Quits, Tetraphase Receives Sweetened Offer",2020-05-28 08:24:00-04:00,GERN,neutral
542796.0,71 Biggest Movers From Friday,2020-05-26 04:30:00-04:00,GERN,neutral
542797.0,The Week Ahead In Biotech: ASCO Presentations In The Spotlight,2020-05-24 14:40:00-04:00,GERN,neutral
542798.0,46 Stocks Moving In Friday's Mid-Day Session,2020-05-22 12:45:00-04:00,GERN,neutral
542799.0,Mid-Day Market Update: LiveRamp Surges Following Q4 Results; Syndax Pharmaceuticals Shares Plummet,2020-05-22 12:39:00-04:00,GERN,positive
542800.0,P/E Ratio Insights for Geron,2020-05-22 11:11:00-04:00,GERN,neutral
542801.0,20 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-05-22 07:47:00-04:00,GERN,neutral
542802.0,Geron shares are trading lower after the company announced a proposed public offering of common stock and warrants. No terms were disclosed.,2020-05-22 07:43:00-04:00,GERN,negative
542803.0,30 Stocks Moving in Friday's Pre-Market Session,2020-05-22 07:18:00-04:00,GERN,neutral
542804.0,Geron Corporation Announces Pricing Of Public Offering Of Common Stock And Warrants,2020-05-22 07:17:00-04:00,GERN,neutral
542805.0,"The Daily Biotech Pulse: FDA Nod For Aquestive, Tetraphase M&A Plot Thickens, Amarin's Vascepa In COVID Fray",2020-05-22 07:10:00-04:00,GERN,neutral
542806.0,8 Stocks Moving In Thursday's After-Hours Session,2020-05-21 16:53:00-04:00,GERN,neutral
542807.0,Geron shares are trading lower after the company announced a proposed public offering of common stock and warrants. No terms were disclosed.,2020-05-21 16:07:00-04:00,GERN,negative
542808.0,Geron Corporation Announces Proposed Public Offering of Common Stock and Warrants; No Terms Disclosed,2020-05-21 16:04:00-04:00,GERN,negative
542809.0,Geron Announces Plans for Imetelstat Phase 3 Clinical Trial in Myelofibrosis and Other Updates,2020-05-21 16:02:00-04:00,GERN,neutral
542810.0,"The Daily Biotech Pulse: FDA Nod For Roche, Arbutus Releases Positive Readout For HBV Therapy, Moderna Announces $1.34B Common Stock Offering",2020-05-19 08:24:00-04:00,GERN,positive
542811.0,Stocks That Hit 52-Week Highs On Monday,2020-05-18 10:44:00-04:00,GERN,neutral
542812.0,Shares of several healthcare companies are trading higher in sympathy with the overall market as optimism around a coronavirus vaccine increased following news from Moderna.,2020-05-18 10:23:00-04:00,GERN,positive
542813.0,Geron To Give 4 Presentations On Imetelstat At European Hematology Association Congress Jun. 11-14,2020-05-14 09:24:00-04:00,GERN,neutral
542814.0,"BTIG Maintains Buy on Geron, Lowers Price Target to $3",2020-04-03 08:18:00-04:00,GERN,negative
542815.0,Geron Expects 2020 Spending To Be Lower Than The $70M-$75M Guidance Range,2020-04-02 08:25:00-04:00,GERN,negative
542816.0,"B. Riley FBR Maintains Buy on Geron, Lowers Price Target to $3.5",2020-03-17 07:52:00-04:00,GERN,negative
542817.0,Geron Q4 EPS $(0.15) Beats $(0.2) Estimate,2020-03-12 16:12:00-04:00,GERN,neutral
542818.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,GERN,negative
542819.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,GERN,negative
542820.0,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index",2020-03-10 09:19:00-04:00,GERN,negative
542821.0,Stocks That Hit 52-Week Lows On Friday,2020-02-28 10:16:00-05:00,GERN,negative
542822.0,"The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO",2020-02-28 07:28:00-05:00,GERN,neutral
542823.0,Stocks That Hit 52-Week Lows On Thursday,2020-02-27 10:23:00-05:00,GERN,negative
542824.0,Geron Reports Conducted End-Of-Phase 2 Meeting For Imetelstat In Relapse/Refractory Myelofibrosis,2019-12-18 16:31:00-05:00,GERN,neutral
542825.0,"The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling",2019-12-07 08:35:00-05:00,GERN,positive
542826.0,"B. Riley FBR Reinstates Buy on Geron, Announces $4 Price Target",2019-11-19 08:31:00-05:00,GERN,neutral
542827.0,Geron Sees FY19 Total Operating Expenses $80M-$85M,2019-11-06 16:24:00-05:00,GERN,neutral
542828.0,"Geron Q3 EPS $(0.08) Beats $(0.15) Estimate, Sales $131K Beat $50K Estimate",2019-11-06 16:23:00-05:00,GERN,neutral
542829.0,"The Daily Biotech Pulse: Sesen Rallies On Positive FDA Meeting, Supernus Flunks Late-Stage ADHD Trial, GW Pharma Earnings",2019-11-06 08:21:00-05:00,GERN,positive
542830.0,28 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-10-11 08:42:00-04:00,GERN,neutral
542831.0,Geron Reports First Patient Dosed In IMerge Phase 3 Trial In Lower Risk Myelodysplastic Syndromes,2019-10-10 17:30:00-04:00,GERN,negative
542832.0,52 Biggest Movers From Yesterday,2019-10-02 04:22:00-04:00,GERN,neutral
542833.0,38 Stocks Moving In Tuesday's Mid-Day Session,2019-10-01 11:59:00-04:00,GERN,neutral
542834.0,23 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-10-01 08:24:00-04:00,GERN,neutral
542835.0,26 Stocks Moving in Tuesday's Pre-Market Session,2019-10-01 08:18:00-04:00,GERN,neutral
542836.0,"The Daily Biotech Pulse: Safety Scare For Anaptys' Psoriasis Drug, NewLink Genetics To Merge With Lumos, Insider Buy Props Up VBI Vaccines",2019-10-01 08:10:00-04:00,GERN,negative
542837.0,Geron shares are trading higher after the company received FDA Fast Track designation for Imetelstat for relapsed/refractory Myelofibrosis.,2019-10-01 07:18:00-04:00,GERN,positive
542838.0,A Peek Into The Markets: US Stock Futures Rise Ahead Of Manufacturing Data,2019-10-01 06:33:00-04:00,GERN,neutral
542839.0,"5 Stocks To Watch For October 1, 2019",2019-10-01 05:54:00-04:00,GERN,neutral
542840.0,4 Stocks Moving In Monday's After-Hours Session,2019-09-30 17:04:00-04:00,GERN,neutral
542841.0,Geron shares are trading higher after the company received FDA Fast Track designation for Imetelstat for relapsed/refractory Myelofibrosis.,2019-09-30 16:23:00-04:00,GERN,positive
542842.0,Geron Corporation Receives FDA Fast Track Designation For Imetelstat For Relapsed/Refractory Myelofibrosis,2019-09-30 16:19:00-04:00,GERN,neutral
542843.0,"Shares of several healthcare companies are trading lower, potentially on recent Democratic primary polls showing Senator Elizabeth Warren in the lead.",2019-09-26 12:43:00-04:00,GERN,neutral
542844.0,Shares of many pharma/therapeutics stocks trading lower in sympathy with overall market weakness. Reports China is planning to cut prices for widely-used drugs may also be pressuring the sector today.,2019-09-24 14:01:00-04:00,GERN,negative
542845.0,24 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-09-13 08:44:00-04:00,GERN,neutral
542846.0,"Benzinga's Top Upgrades, Downgrades For September 3, 2019",2019-09-03 09:42:00-04:00,GERN,positive
542847.0,"H.C. Wainwright Initiates Coverage On Geron with Buy Rating, Announces $4 Price Target",2019-09-03 08:12:00-04:00,GERN,neutral
542848.0,33 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-08-19 08:47:00-04:00,GERN,neutral
542849.0,"Benzinga's Top Upgrades, Downgrades For August 15, 2019",2019-08-15 09:38:00-04:00,GERN,positive
542850.0,26 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-08-15 08:42:00-04:00,GERN,neutral
542851.0,Geron shares are trading higher after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and a price target of $4 per share.,2019-08-15 08:25:00-04:00,GERN,positive
542852.0,"Cantor Fitzgerald Initiates Coverage On Geron with Overweight Rating, Announces $4 Price Target",2019-08-15 08:16:00-04:00,GERN,negative
542853.0,Geron Reports Initiation Of Phase 3 Trial In Lower Risk Myelodysplastic Syndromes,2019-08-08 09:54:00-04:00,GERN,negative
542854.0,40 Healthcare Stocks Moving In Thursday's After-Market Session,2019-08-02 04:10:00-04:00,GERN,neutral
542855.0,"Geron Q2 EPS $(0.08) Beats $(0.09) Estimate, Sales $101K Beat $100K Estimate",2019-08-01 16:11:00-04:00,GERN,neutral
542856.0,"The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings",2019-08-01 07:18:00-04:00,GERN,negative
542857.0,"The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate",2019-07-27 14:32:00-04:00,GERN,negative
542858.0,35 Healthcare Stocks Moving In Wednesday's After-Market Session,2019-07-25 05:55:00-04:00,GERN,neutral
542859.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts",2019-06-08 16:09:00-04:00,GERN,neutral
542860.0,Geron Highlights 2 Presentations On Imetelstat For Upcoming European Hematology Association Annual,2019-05-16 09:14:00-04:00,GERN,neutral
542861.0,Geron Raises FY19 Opex Guidance To $80M-$85M,2019-05-16 08:14:00-04:00,GERN,neutral
542862.0,Geron Offers Update On Imetelstat Program,2019-05-16 08:14:00-04:00,GERN,neutral
542863.0,Geron Q1 EPS $(0.05) Down From $(0.04) YoY,2019-05-02 16:29:00-04:00,GERN,neutral
542864.0,"Geron's Blood Cancer Candidate Creates Buying Opportunity, Needham Says In Upgrade",2019-04-09 14:50:00-04:00,GERN,negative
542865.0,"UPDATE: Needham Upgrades Geron To Buy, Announces $3 Target As Firm Believes 'negative optics of a big pharma passing on imetelstat, and not a fundamental issue with the drug itself, have created a buying opportunity for GERN shares'",2019-04-09 10:01:00-04:00,GERN,positive
542866.0,"Benzinga's Top Upgrades, Downgrades For April 9, 2019",2019-04-09 09:16:00-04:00,GERN,positive
542867.0,Geron Corp shares are trading higher after Needham upgraded the stock from Hold to Buy and announced a $3 price target.,2019-04-09 07:54:00-04:00,GERN,positive
542868.0,"Needham Upgrades Geron to Buy, Announces $3 Price Target",2019-04-09 06:39:00-04:00,GERN,neutral
542869.0,"Geron Q4 EPS $(0.05), Same YoY, Sales $375K Up From $191K YoY",2019-03-07 16:48:00-05:00,GERN,neutral
542870.0,Geron Option Alert: Jan 17 $0.5 Calls at the Ask: 500 @ $1.051 vs 483 OI; Earnings 3/7 After Close Ref=$1.445,2019-03-07 11:56:00-05:00,GERN,positive
542871.0,"Daily Biotech Pulse: Allergan's Depression Drug Flunks Late-Stage Trial, Apellis Offering, ShockWave Medical IPO",2019-03-07 07:48:00-05:00,GERN,negative
542872.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs",2019-03-03 09:41:00-05:00,GERN,neutral
542873.0,Traders Circulating Weekend Motley Fool Article 'Could Geron Be a Millionaire-Maker Stock?',2019-02-25 10:24:00-05:00,GERN,negative
542874.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Thurs., Feb. 14, 2019",2019-02-14 09:45:00-05:00,GERN,positive
542875.0,"Benzinga's Top Upgrades, Downgrades For February 13, 2019",2019-02-13 09:11:00-05:00,GERN,positive
542876.0,UPDATE: BTIG Initiates Geron With Buy As Firm Notes 'Imetelstat's efficacy looks similar to luspatercept's (in much more severe patients) suggesting Geron is likely to attract investor interest as corroborative pivotal readouts approach',2019-02-13 09:02:00-05:00,GERN,positive
542877.0,"BTIG Research Initiates Coverage On Geron with Buy Rating, Announces $4 Price Target",2019-02-13 07:02:00-05:00,GERN,neutral
542878.0,"UPDATE: B Riley FBR Believes Geron's 'imetelstat could meet an unmet medical need and provide a meaningful clinical benefit in treating MDS patients who are relapsed or refractory to, or ineligible for, erythropoiesis-stimulating agents'",2019-01-31 11:53:00-05:00,GERN,positive
542879.0,UPDATE: B Riley FBR Upgrades Geron 'based on a revised analysis of the potential market opportunity for Geron's only drug candidate in treating patients with a risk of low- to intermediate-1 (int-1) myelodysplastic syndrome',2019-01-31 11:51:00-05:00,GERN,negative
542880.0,"Benzinga's Top Upgrades, Downgrades For January 31, 2019",2019-01-31 09:11:00-05:00,GERN,positive
542881.0,B. Riley FBR Upgrades Geron to Buy,2019-01-31 08:00:00-05:00,GERN,neutral
542882.0,"Geron Reports Chair Hoyoung Huh Resigned; Pres, CEO John Scarlett Named Replacement",2018-12-31 07:34:00-05:00,GERN,negative
542883.0,"The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",2018-12-21 07:58:00-05:00,GERN,neutral
542884.0,"The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum",2018-12-20 07:53:00-05:00,GERN,positive
542885.0,"The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas",2018-12-19 07:46:00-05:00,GERN,positive
542886.0,"The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan",2018-12-18 08:00:00-05:00,GERN,positive
542887.0,"Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018",2018-12-17 11:48:00-05:00,GERN,negative
542888.0,"The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings",2018-12-11 08:22:00-05:00,GERN,neutral
542889.0,"Stocks Which Set New 52-Week Low The Last Trading Session, Fri., Dec. 7, 2018",2018-12-10 11:01:00-05:00,GERN,negative
542890.0,Geron Announces New Overall Survival Data From IMbark In Imetelstat-Treated Patients With Intermediate-2 Or High-Risk Myelofibrosis And Relapsed/Refractory To Janus Kinase Inhibitor Therapy ; Reports Median Overall Survival Of 29.9 Months In High-Dose Arm,2018-12-03 16:23:00-05:00,GERN,negative
542891.0,Geron Says Phase 2 Results of its IMerge Study Support Initiating the Phase 3 Portion,2018-12-03 06:06:00-05:00,GERN,positive
542892.0,"The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs",2018-12-02 17:51:00-05:00,GERN,neutral
542893.0,"Geron Corporation Q3 EPS $(0.03) Beats $(0.05) Estimate, Sales $165K Miss $210K Estimate",2018-11-01 17:30:00-04:00,GERN,negative
542894.0,"The Daily Biotech Pulse: AbbVie's Leukemia Drug Trial Meets Endpoint, Denali Strikes Collaboration Deal",2018-11-01 07:30:00-04:00,GERN,negative
542895.0,Geron Announces Two Oral Presentations on Imetelstat at Upcoming American Society of Hematology Annual Meeting,2018-11-01 06:21:00-04:00,GERN,neutral
542896.0,"Stocks Which Set New 52-Week Low Yesterday, October 29th",2018-10-30 12:40:00-04:00,GERN,negative
542897.0,46 Biggest Movers From Friday,2018-10-01 04:20:00-04:00,GERN,neutral
542898.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-09-30 10:14:00-04:00,GERN,neutral
542899.0,"Benzinga's Bulls & Bears Of The Week: Apple, GE, IBM, Nike, Tesla And More",2018-09-30 09:47:00-04:00,GERN,neutral
542900.0,Mid-Afternoon Market Update: Progress Software Falls Following Mixed Q3 Results; ChemoCentryx Shares Climb,2018-09-28 14:35:00-04:00,GERN,positive
542901.0,34 Stocks Moving In Friday's Mid-Day Session,2018-09-28 12:41:00-04:00,GERN,neutral
542902.0,Mid-Day Market Update: Crude Oil Up 1.5%; Altimmune Shares Plunge,2018-09-28 12:02:00-04:00,GERN,negative
542903.0,Mid-Morning Market Update: Markets Edge Lower; BlackBerry Earnings Beat Expectations,2018-09-28 10:24:00-04:00,GERN,negative
542904.0,26 Stocks Moving In Friday's Pre-Market Session,2018-09-28 08:13:00-04:00,GERN,neutral
542905.0,51 Biggest Movers From Yesterday,2018-09-28 05:15:00-04:00,GERN,neutral
542906.0,6 Stocks Moving In Thursday's After-Hours Session,2018-09-27 16:49:00-04:00,GERN,neutral
542907.0,Mid-Afternoon Market Update: Bed Bath & Beyond Drops Following Weak Q2 Results; Cameco Shares Surge,2018-09-27 14:31:00-04:00,GERN,negative
542908.0,36 Stocks Moving In Thursday's Mid-Day Session,2018-09-27 12:37:00-04:00,GERN,neutral
542909.0,Mid-Day Market Update: Dow Rises Over 100 Points; Geron Shares Plunge,2018-09-27 12:06:00-04:00,GERN,positive
542910.0,Mid-Morning Market Update: Markets Open Higher; Conagra Misses Q1 Views,2018-09-27 10:14:00-04:00,GERN,negative
542911.0,Geron Plunges As Johnson & Johnson Unit Discontinues Blood Cancer Drug Collaboration,2018-09-27 09:51:00-04:00,GERN,negative
542912.0,"The Daily Biotech Pulse: Hologic Goes Shopping, Johnson & Johnson Snaps Ties With Geron",2018-09-27 08:20:00-04:00,GERN,neutral
542913.0,30 Stocks Moving In Thursday's Pre-Market Session,2018-09-27 08:10:00-04:00,GERN,neutral
542914.0,Geron Reports Discontinuation OF Imetelstat Collaboration With Janssen,2018-09-27 06:03:00-04:00,GERN,neutral
542915.0,"Geron to Provide an Update on the Imetelstat Collaboration with Janssen on September 27, 2018",2018-09-26 20:51:00-04:00,GERN,neutral
542916.0,30 Stocks Moving In Tuesday's Pre-Market Session,2018-09-25 07:40:00-04:00,GERN,neutral
542917.0,51 Biggest Movers From Yesterday,2018-09-25 04:53:00-04:00,GERN,neutral
542918.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-09-23 16:10:00-04:00,GERN,neutral
542919.0,"The Week Ahead In Biotech (Sept. 16-22): Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-09-16 14:22:00-04:00,GERN,neutral
542920.0,"Stocks Which Set New 52-Week High Yesterday, September 13th",2018-09-14 09:26:00-04:00,GERN,neutral
542921.0,24 Stocks Moving In Friday's Pre-Market Session,2018-09-14 08:01:00-04:00,GERN,neutral
542922.0,"'I still believe $JNJ will drop $GERN imetelstat. I guess we wait for later this month to see if I'm right or wrong. Nothing today changes my bearish view. If anything, NOT focusing on imetelstat today is a negative.'-Stat's Adam Feuerstein Tweets",2018-09-13 11:30:00-04:00,GERN,negative
542923.0,"Geron Shares Turn Negative On The Day, Now Down ~3% Following Questions Regarding Imetelstat On Johnson & Johnson's Pharma Business Conf. Call",2018-09-13 11:13:00-04:00,GERN,negative
542924.0,Geron Option Alert: Oct 19 $4 Puts Sweep (4) near the Ask: 500 @ $0.451 vs 23282 OI; Earnings 10/31 After Close [est] Ref=$6.4508,2018-09-13 09:36:00-04:00,GERN,positive
542925.0,Shares Of Geron Spiking Higher As Co.'s Imetelstat Is Listed On Johnson & Johnson's Presentation As 2019-2021 Potential Filings,2018-09-13 09:08:00-04:00,GERN,positive
542926.0,"The Week Ahead In Biotech: Conferences, Clinical Trial Results, Earnings And IPOs",2018-09-09 16:46:00-04:00,GERN,neutral
542927.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings",2018-09-02 09:41:00-04:00,GERN,neutral
542928.0,40 Biggest Movers From Yesterday,2018-08-29 05:18:00-04:00,GERN,neutral
542929.0,38 Biggest Movers From Yesterday,2018-08-28 04:38:00-04:00,GERN,neutral
542930.0,30 Stocks Moving In Monday's Mid-Day Session,2018-08-27 12:49:00-04:00,GERN,neutral
542931.0,44 Biggest Movers From Friday,2018-08-27 04:34:00-04:00,GERN,neutral
542932.0,What's Going On With Geron?,2018-08-24 13:53:00-04:00,GERN,neutral
542933.0,"Geron Shares Fall Modestly, ~3.7%, As J&J Spokesperson Suggests Recent Job Posting Mentioning Imetelstat Is Not Related To An Expected Decision For A Licensing Deal, And Includes 'Responsibilities For A Variety Of Disease Areas'",2018-08-24 12:54:00-04:00,GERN,positive
542934.0,Hearing J&J Spokesperson Has Issued Response Related To Recent Job Posting: Says Posting Not Related To Expected Decision On Licensing Deal,2018-08-24 12:52:00-04:00,GERN,neutral
542935.0,Geron Option Alert: Sep 21 $6 Calls at the Bid: 1898 @ $0.75 vs 5968 OI; Ref=$5.0729,2018-08-24 12:48:00-04:00,GERN,positive
542936.0,40 Stocks Moving In Friday's Mid-Day Session,2018-08-24 12:47:00-04:00,GERN,neutral
542937.0,"Geron Shares Remain Elevated, Up 28.3% With Some Attributing Upside To Johnson & Johnson Job Posting For a Strategic Pricing Manager For Imbruvica & Imetelstat, Drugs Its Partnered On With AbbVie and Geron, Respectively",2018-08-24 10:42:00-04:00,GERN,positive
542938.0,Geron Option Alert: Sep 21 $4 Puts Sweep (8) near the Ask: 890 @ $0.75 vs 5226 OI; Ref=$4.97,2018-08-24 10:19:00-04:00,GERN,positive
542939.0,"'$GERN trading +30% on a JNJ job posting that mentions imetelstat. Yes, it's that ridiculous. Summer Fridays!'-STAT's Adam Feuerstein Tweets",2018-08-24 10:17:00-04:00,GERN,positive
542940.0,Geron Option Alert: Oct 19 $4 Puts Sweep (24) near the Ask: 2339 @ $1.051 vs 348 OI; Ref=$5.45,2018-08-24 10:04:00-04:00,GERN,positive
542941.0,Geron Shares Now Up 37.5%; Traders Circulate Seeking Alpha Article From Very Early Fri. Morning 'Geron: Short Stew Brewing',2018-08-24 10:00:00-04:00,GERN,positive
542942.0,Geron Corp. shares are up 12.9% since yesterday to $4.55 on high volume.,2018-08-24 09:43:00-04:00,GERN,positive
542943.0,Geron Shares Break Above $4.20 Resistance On Heavy Volume; Stock Up ~12.6% Over Last Min.,2018-08-24 09:25:00-04:00,GERN,positive
542944.0,30 Stocks Moving In Friday's Pre-Market Session,2018-08-24 08:08:00-04:00,GERN,neutral
542945.0,"Benzinga's Biotech Pulse: Pfizer's Xeljanz Gets EU Nod, NewLink Losses Narrow, Neuralstem Commences Stroke Drug Trial",2018-08-01 09:01:00-04:00,GERN,negative
542946.0,"Geron Q2 EPS $(0.04), Same YoY, Sales $208K Up From $174K YoY",2018-07-31 16:08:00-04:00,GERN,neutral
542947.0,Geron Option Alert: Aug 17 $4.5 Calls Sweep (35) near the Ask: 2325 @ $0.301 vs 4618 OI; Earnings 7/31 After Close Ref=$3.405,2018-07-31 13:39:00-04:00,GERN,positive
542948.0,Geron Option Alert: Aug 17 $4 Calls Sweep (43) near the Ask: 1996 @ $0.3 vs 4681 OI; Earnings 7/31 After Close Ref=$3.34,2018-07-30 09:54:00-04:00,GERN,positive
542949.0,"'Brain tumor not central to the $GERN imetelstat story but termination for safety is, of course, a problem. Safety issues have plagued imetelstat.'-STAT's Adam Feuerstein Tweets",2018-07-20 10:38:00-04:00,GERN,positive
542950.0,Shares of Geron Down ~3% As The Co.'s Imetelstat's Brain Tumor Trial Was Terminated Due To Several Intracrainial Hemorrhages And Recommendation By The PBTC DSMB,2018-07-20 10:13:00-04:00,GERN,negative
542951.0,30 Stocks Moving In Thursday's Mid-Day Session,2018-07-05 12:24:00-04:00,GERN,neutral
542952.0,"Benzinga's Top Upgrades, Downgrades For July 5, 2018",2018-07-05 09:10:00-04:00,GERN,positive
542953.0,"B. Riley FBR Initiates Coverage On Geron with Buy Rating, Announces $5.75 Price Target",2018-07-05 07:26:00-04:00,GERN,neutral
542954.0,'The success of $XLRN luspatercept is bad for $GERN and another reason for $JNJ to sever the imetelstat relationship in Q3.'-STAT's Adam Feuerstein Tweets,2018-06-29 10:01:00-04:00,GERN,positive
542955.0,"'$GERN wants $JNJ to continue a drug development partnership, but new data weaken its case'-STAT's Adam Feuerstein Tweets",2018-06-18 11:48:00-04:00,GERN,negative
542956.0,26 Stocks Moving In Monday's Pre-Market Session,2018-06-18 08:23:00-04:00,GERN,neutral
542957.0,Geron S-3 Shows Registration For $250M Mixed Securities Shelf Offering,2018-05-24 16:53:00-04:00,GERN,positive
542958.0,BZ NOTE: Ealier Geron Post Of Traders Circulating A Supposed Halt Of Imetelstat's Study In Germany Is From 2015,2018-05-24 11:41:00-04:00,GERN,positive
542959.0,Traders Circulating EU Clincial Trials Register Page That Says Geron's Imetelstat Study Halted In Germany,2018-05-24 11:23:00-04:00,GERN,neutral
542960.0,38 Biggest Movers From Yesterday,2018-05-24 04:44:00-04:00,GERN,neutral
542961.0,38 Biggest Movers From Yesterday,2018-05-23 04:56:00-04:00,GERN,neutral
542962.0,50 Biggest Movers From Friday,2018-05-14 05:07:00-04:00,GERN,neutral
542963.0,38 Stocks Moving In Friday's Mid-Day Session,2018-05-11 12:28:00-04:00,GERN,neutral
542964.0,"Benzinga's Daily Biotech Pulse: FDA Panel Nod For Akcea, Synergy's Revenue Miss, FDA Warns E-Liquid Makers Again",2018-05-11 08:21:00-04:00,GERN,negative
542965.0,22 Stocks Moving In Friday's Pre-Market Session,2018-05-11 08:03:00-04:00,GERN,neutral
542966.0,"Geron Q1 EPS $(0.04) Beats $(0.05) Estimate, Sales $318K Down From $537K YoY",2018-05-10 16:47:00-04:00,GERN,neutral
542967.0,"Jim Cramer Shares His Thoughts On Goodyear, Applied Materials And More",2018-05-02 07:11:00-04:00,GERN,positive
542968.0,"Tellurian, Applied Optoelectronics Capture Short Sellers' Attention",2018-04-24 15:18:00-04:00,GERN,neutral
542969.0,28 Stocks Moving In Tuesday's Pre-Market Session,2018-04-24 08:01:00-04:00,GERN,neutral
542970.0,28 Stocks Moving In Friday's Pre-Market Session,2018-04-13 08:12:00-04:00,GERN,neutral
542971.0,41 Biggest Movers From Yesterday,2018-04-13 05:04:00-04:00,GERN,neutral
542972.0,33 Stocks Moving In Monday's Mid-Day Session,2018-04-02 12:53:00-04:00,GERN,neutral
542973.0,28 Stocks Moving In Monday's Pre-Market Session,2018-04-02 08:00:00-04:00,GERN,neutral
542974.0,36 Stocks Moving In Thursday's Mid-Day Session,2018-03-29 12:21:00-04:00,GERN,neutral
542975.0,26 Stocks Moving In Thursday's Pre-Market Session,2018-03-29 08:22:00-04:00,GERN,neutral
542976.0,40 Biggest Movers From Yesterday,2018-03-29 05:08:00-04:00,GERN,neutral
542977.0,32 Stocks Moving In Wednesday's Mid-Day Session,2018-03-28 12:45:00-04:00,GERN,neutral
542978.0,28 Stocks Moving In Wednesday's Pre-Market Session,2018-03-28 08:19:00-04:00,GERN,neutral
542979.0,38 Biggest Movers From Yesterday,2018-03-28 05:19:00-04:00,GERN,neutral
542980.0,"Benzinga Pro's Most-Searched Tickers For Tues., Mar. 27, 2018",2018-03-27 15:58:00-04:00,GERN,neutral
542981.0,30 Stocks Moving In Tuesday's Mid-Day Session,2018-03-27 12:31:00-04:00,GERN,neutral
542982.0,24 Stocks Moving In Tuesday's Pre-Market Session,2018-03-27 08:02:00-04:00,GERN,neutral
542983.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Mon., Mar. 26, 2018",2018-03-26 17:54:00-04:00,GERN,positive
542984.0,42 Biggest Movers From Friday,2018-03-26 05:13:00-04:00,GERN,neutral
542985.0,30 Stocks Moving In Friday's Mid-Day Session,2018-03-23 13:10:00-04:00,GERN,neutral
542986.0,25 Stocks Moving In Friday's Pre-Market Session,2018-03-23 08:09:00-04:00,GERN,neutral
542987.0,41 Biggest Movers From Yesterday,2018-03-23 04:52:00-04:00,GERN,neutral
542988.0,28 Stocks Moving In Thursday's Mid-Day Session,2018-03-22 12:47:00-04:00,GERN,neutral
542989.0,Watching Shares of Geron As Negative Blog Post Circulated By Traders Says 'Geron's Negative Imetelstat Data Has Been Misinterpreted By Investors',2018-03-22 10:57:00-04:00,GERN,negative
542990.0,21 Stocks Moving In Thursday's Pre-Market Session,2018-03-22 08:24:00-04:00,GERN,neutral
542991.0,33 Biggest Movers From Yesterday,2018-03-22 04:47:00-04:00,GERN,neutral
542992.0,27 Stocks Moving In Wednesday's Mid-Day Session,2018-03-21 12:48:00-04:00,GERN,neutral
542993.0,20 Stocks Moving In Wednesday's Pre-Market Session,2018-03-21 08:19:00-04:00,GERN,neutral
542994.0,"Benzinga Pro's Most-Searched Tickers For Tues., Mar. 20",2018-03-20 14:49:00-04:00,GERN,neutral
542995.0,42 Biggest Movers From Yesterday,2018-03-20 04:48:00-04:00,GERN,neutral
542996.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Mon., Mar. 19",2018-03-19 17:25:00-04:00,GERN,positive
542997.0,Mid-Afternoon Market Update: NASDAQ Slides Over 2.5%; Micro Focus Shares Plummet,2018-03-19 14:32:00-04:00,GERN,positive
542998.0,31 Stocks Moving In Monday's Mid-Day Session,2018-03-19 12:49:00-04:00,GERN,neutral
542999.0,Mid-Day Market Update: Dow Falls Over 300 Points; Klondex Mines Shares Spike Higher,2018-03-19 12:03:00-04:00,GERN,positive
543000.0,Mid-Morning Market Update: Markets Open Lower; KLA-Tencor To Buy Orbotech,2018-03-19 10:14:00-04:00,GERN,negative
543001.0,25 Stocks Moving In Monday's Pre-Market Session,2018-03-19 08:01:00-04:00,GERN,neutral
543002.0,"Geron Reports Q4 EPS $(0.05), Inline, Sales $191K Misses $270K Est.",2018-03-16 16:11:00-04:00,GERN,negative
543003.0,55 Biggest Movers From Yesterday,2018-03-16 05:14:00-04:00,GERN,neutral
543004.0,"Earnings Scheduled For March 16, 2018",2018-03-16 05:04:00-04:00,GERN,neutral
543005.0,Mid-Afternoon Market Update: Image Sensing Systems Gains Following Q4 Results; J.Jill Shares Plummet,2018-03-15 14:33:00-04:00,GERN,positive
543006.0,Geron Option Alert: Fri $2 Calls Sweep (2) at the Ask: 983 @ $1.551 vs 3918 OI; Earnings 5/8 After Close [est] Ref=$3.579,2018-03-15 12:53:00-04:00,GERN,positive
543007.0,Mid-Day Market Update: Dow Rises Over 200 Points; Invuity Shares Plummet,2018-03-15 12:25:00-04:00,GERN,positive
543008.0,UPDATE: Alpha Exposure Report On Geron Shows $0.47 Price Target,2018-02-09 10:01:00-05:00,GERN,neutral
543009.0,UPDATE: SeekingAlpha Contributor Alpha Exposure Publishes 'Geron: Imetelstat's History Of Deaths And Safety Issues',2018-02-09 10:01:00-05:00,GERN,positive
543010.0,Geron Shares Ticking ~$0.06 Lower As Traders Circulating Negative SeekingAlpha Report On Name,2018-02-09 09:59:00-05:00,GERN,negative
543011.0,Mid-Afternoon Market Update: Crude Oil Down 1.5%; Natural Grocers Shares Drop On Earnings Miss,2018-02-02 14:31:00-05:00,GERN,negative
543012.0,Geron Option Alert: Jun 15 $3 Calls Sweep (9) at the Ask: 841 @ $0.701 vs 2908 OI; Earnings 2/28 After Close [est] Ref=$2.51,2018-01-31 13:33:00-05:00,GERN,positive
543013.0,Geron Option Alert: Jun 15 $2 Calls at the Ask: 500 @ $1.051 vs 7539 OI; Earnings 2/28 After Close [est] Ref=$2.53,2018-01-30 10:11:00-05:00,GERN,positive
543014.0,38 Biggest Movers From Yesterday,2018-01-30 04:37:00-05:00,GERN,neutral
543015.0,Geron Option Alert: Jun 15 $4 Puts at the Ask: 580 @ $2.101 vs 1023 OI; Ref=$2.0162,2017-12-11 10:13:00-05:00,GERN,positive
543016.0,Geron Shares Flat; Earlier Co. Reported 1st Patient Dosed In Expanded Pt. 1 IMerge Trial Of Imetelstat,2017-11-20 11:50:00-05:00,GERN,positive
543017.0,Geron Shares Down 8.2% Following Yesterday's Stat News Article From Adam Feuerstein Highlighting An Alarming Item In Geron's 10-Q Statement Related To imetelstat,2017-11-14 11:36:00-05:00,GERN,positive
543018.0,9 Notable Biotechs Presenting At This Year's ASH Meeting,2017-11-06 16:31:00-05:00,GERN,neutral
543019.0,"Geron Corporation Reports Q3 EPS $(0.04) vs. $(0.05) Est., Sales $163K vs. $260K Est.",2017-11-01 17:04:00-04:00,GERN,neutral
543020.0,46 Biggest Movers From Yesterday,2017-11-01 05:27:00-04:00,GERN,neutral
543021.0,38 Stocks Moving In Tuesday's Mid-Day Session,2017-10-31 12:31:00-04:00,GERN,neutral
543022.0,28 Stocks Moving In Tuesday's Pre-Market Session,2017-10-31 08:09:00-04:00,GERN,neutral
543023.0,Geron Reports Fast Track Designation Granted To Imetelstat For Lower Risk Myelodysplastic Syndromes,2017-10-31 07:44:00-04:00,GERN,negative
543024.0,"Geron Reports Q2 EPS $(0.04) vs $(0.05) Est., Sales $174K vs $260K Est.",2017-08-09 16:17:00-04:00,GERN,neutral
543025.0,Mid-Day Market Update: Pitney Bowes Drops On Earnings Miss; Lumber Liquidators Shares Climb,2017-08-01 12:03:00-04:00,GERN,positive
543030.0,Geron Drops to Low of $2.50 on Volume,2017-06-05 11:07:00-04:00,GERN,negative
543031.0,"Geron Reports Q1 EPS $(0.05) In-line With Est., Sales $537K vs $180K Est.",2017-05-09 17:20:00-04:00,GERN,neutral
543032.0,20 Stocks Moving In Tuesday's Pre-Market Session,2017-04-11 09:27:00-04:00,GERN,neutral
543033.0,14 Biggest Mid-Day Gainers For Monday,2017-04-10 14:06:00-04:00,GERN,neutral
543034.0,16 Stocks Moving In Monday's Pre-Market Session,2017-04-10 08:54:00-04:00,GERN,neutral
543035.0,From Conf Call: Geron Says Jansen has Right to Terminate Agreement at Any Time for Any Reason,2017-04-10 08:19:00-04:00,GERN,positive
543036.0,Geron Conf Call Begins,2017-04-10 08:04:00-04:00,GERN,neutral
543037.0,"Adam Feuerstein Tweets: $JNJ reluctance to commit to imetelstat, disclosed in last sentence of $GERN PR, is most important point.",2017-04-10 07:41:00-04:00,GERN,positive
543038.0,Adam Feuerstein Tweets: $GERN — This imetelstat PR is a lukewarm bowl of gruel. Filling but not very tasty. And J&J still has not committed to continue development.,2017-04-10 07:41:00-04:00,GERN,negative
543039.0,Geron Announces Completion of Second Internal Data Reviews for Imetelstat Trials Being Conducted by Janssen,2017-04-10 07:33:00-04:00,GERN,neutral
543040.0,Geron +18.14% Premarket @$2.54; Co to Host Conference Call at 8:00 a.m. ET to Provide Update on Ongoing Imetelstat Trials,2017-04-10 07:25:00-04:00,GERN,neutral
543041.0,"Geron to Host Conference Call April 10, 2017, at 8:00 a.m. ET to Provide Update on Ongoing Imetelstat Trials",2017-04-09 19:14:00-04:00,GERN,neutral
543042.0,Watch These 8 Huge Put Purchases In Tuesday Trade,2017-04-04 04:57:00-04:00,GERN,positive
543043.0,Benzinga's Option Alert Recap From April 3,2017-04-03 16:27:00-04:00,GERN,positive
543044.0,Option Alert: Geron Apr 2.0 Puts Sweep: 3262 @  ASK  $0.10: 3292 traded vs 2853 OI:  Earnings 5/4 After Close (est)  $2.38 Ref,2017-04-03 10:40:00-04:00,GERN,positive
543045.0,"UPDATE: Geron Has Agreed to Settle Securities Claiss Action Suit for $6.25M in Cash, of Which $6M Will be Paid by Co.'s Insurance Providers",2017-03-03 07:36:00-05:00,GERN,positive
543046.0,"8-K from Geron Shows Stipulation, Agreement of Settlement Formalizing Securities Class Action Suit to be Settled",2017-03-03 07:35:00-05:00,GERN,positive
543047.0,"Geron Reports Q4 EPS $(0.05) vs $(0.06) Est., Sales $94K vs $130K Est.",2017-03-01 16:27:00-05:00,GERN,neutral
543048.0,Benzinga's Option Alert Recap From January 23,2017-01-23 17:12:00-05:00,GERN,positive
543049.0,Option Alert: Geron Feb 2.0 Calls Sweep: 779 @  ASK  $0.15: 877 traded vs 1118 OI:  Earnings 2/23 After Close (est)  $1.90 Ref,2017-01-23 12:34:00-05:00,GERN,positive
543050.0,22 Stocks Moving In Wednesday's Pre-Market Session,2017-01-11 08:22:00-05:00,GERN,neutral
543051.0,BioTime CEO Explains What Could Happen To Stem Cell Research And The Company Under A New Guard In Washington,2016-11-22 12:05:00-05:00,GERN,neutral
543052.0,BioTime CEO Shares Updates On Spinal Cord Injury And Dry AMD Therapies,2016-11-21 15:36:00-05:00,GERN,negative
543053.0,BioTime CEO Explains Stem Cells And How The Company Uses Them,2016-11-20 20:03:00-05:00,GERN,neutral
543054.0,"In Latest Johnson & Johnson 10-Q, Company Reported A Patient Death In Janssen's IMBbark and IMerge With Adverse Events Associated With Geron's imetelstat",2016-11-04 10:00:00-04:00,GERN,negative
543055.0,"Geron Corp. Reports Q3 EPS $(0.02) vs. Est. $(0.06), Rev. $5.1M vs. Est. $160K",2016-11-03 17:23:00-04:00,GERN,neutral
543056.0,18 Stocks Moving In Monday's Pre-Market Session,2016-10-03 08:30:00-04:00,GERN,neutral
543057.0,15 Biggest Mid-Day Gainers For Monday,2016-09-19 12:36:00-04:00,GERN,neutral
543058.0,15 Stocks Moving In Monday's Pre-Market Session,2016-09-19 08:25:00-04:00,GERN,neutral
543059.0,A Chronology Of Geron's Imetelstat,2016-09-14 12:47:00-04:00,GERN,neutral
543060.0,Mid-Afternoon Market Update: Dow Surges Over 200 Points; Geron Shares Tumble,2016-09-12 14:17:00-04:00,GERN,positive
543061.0,12 Biggest Mid-Day Losers For Monday,2016-09-12 12:54:00-04:00,GERN,negative
543062.0,Mid-Day Market Update: American Farmland Gains Following Merger News; RetailMeNot Shares Drop,2016-09-12 12:15:00-04:00,GERN,positive
543063.0,Mid-Morning Market Update: Markets Rise; Horizon Pharma To Buy Raptor Pharmaceutical For $9/Share,2016-09-12 10:31:00-04:00,GERN,neutral
543064.0,TheStreet's Adam Feuerstein Recently Tweets 'That $GERN imetelstat update looks bad. This explains why $GERN not $JNJ issued today's PR. That drug's on life support.',2016-09-12 09:21:00-04:00,GERN,negative
543065.0,10 Stocks Moving In Monday's Pre-Market Session,2016-09-12 08:37:00-04:00,GERN,neutral
543066.0,Geron +13.64% @$3.25 Following Update on  Imetelstat,2016-09-12 07:38:00-04:00,GERN,neutral
543067.0,Geron Provides Update on Imetelstat Trials Being Conducted by Janssen,2016-09-12 07:32:00-04:00,GERN,neutral
543068.0,Watch These 5 Huge Put Purchases In Tuesday Trade,2016-08-30 02:30:00-04:00,GERN,positive
543069.0,Option Alert: GERN Oct16 2.0 Puts Sweep: 1500 @  ASK  $0.10: 1500 traded vs 0 OI: $2.66 Ref,2016-08-29 11:29:00-04:00,GERN,positive
543070.0,Geron Shares Seen Range-Bound On Lack Of Major Data Until Late 2017,2016-08-19 12:28:00-04:00,GERN,neutral
543071.0,BTIG Research Initiates Coverage on Geron at Neutral,2016-08-19 07:57:00-04:00,GERN,neutral
543072.0,"Geron Corp. Reports Q2 EPS $0.05 vs. Est. $(0.07), Rev. $211K vs. Est. $300K",2016-08-03 16:56:00-04:00,GERN,neutral
543073.0,12 Stocks Moving In Wednesday's Pre-Market Session,2016-07-13 08:23:00-04:00,GERN,neutral
543074.0,Geron Reports Issuance of US Patents Related to Imetelstat,2016-07-13 07:31:00-04:00,GERN,neutral
543075.0,Option Alert: GERN Jan17 4.0 Calls Sweep: 500 @  ASK  $0.30: 505 traded vs 4963 OI:  Earnings 8/3  $2.76 Ref,2016-07-11 15:07:00-04:00,GERN,positive
543076.0,Geron Corp Reports Inline Q1 EPS $(0.06),2016-05-05 17:20:00-04:00,GERN,neutral
543077.0,Geron Mixed After Company Announces Start Of Phase 2/3 Clinical Trial,2016-01-14 11:42:00-05:00,GERN,neutral
543078.0,Geron Reports Start of Janssen Phase 2/3 Clinical Trial of Imetelstat in Myelodysplastic Syndromes,2016-01-14 07:30:00-05:00,GERN,neutral
543079.0,Option Alert: GERN Mar16 3.5 Calls Sweep: 600 @  ASK  $0.50: 680 traded vs 837 OI:  Earnings 3/1  $3.42 Ref,2016-01-11 14:56:00-05:00,GERN,positive
543080.0,Option Alert: GERN Dec15 5.0 Calls Sweep: 500 @  ASK  $0.10: 1001 traded vs 4398 OI: $4.48 Ref,2015-12-10 11:41:00-05:00,GERN,positive
543081.0,Piper Jaffray Sees Strength In Geron After News Of Drug Development,2015-12-07 10:29:00-05:00,GERN,positive
543082.0,Benzinga's Top #PreMarket Gainers,2015-12-07 08:27:00-05:00,GERN,positive
543083.0,Benzinga's Top #PreMarket Losers,2015-12-03 08:18:00-05:00,GERN,negative
543084.0,15 Biotechs Making Announcements At The 2015 Piper Jaffray Healthcare Conference,2015-12-01 16:45:00-05:00,GERN,neutral
543085.0,Option Alert: $GERN Dec $5 Call Sweep; 700 Contracts @ Ask @$0.40; Ref $4.91,2015-12-01 10:47:00-05:00,GERN,positive
543086.0,Option Alert: $GERN Jan $4 Call; 500 Contracts @Ask @$1.30; Ref $5.11,2015-11-30 12:13:00-05:00,GERN,positive
543087.0,"Geron Corp. Reports Q3 EPS $0.17 vs. Est. $0.11, Rev. $35.4M vs. Est. $21.35M",2015-11-05 17:28:00-05:00,GERN,neutral
543088.0,One Way To Bet On The American Society Of Hematology's Meeting Next Month,2015-09-22 15:48:00-04:00,GERN,neutral
543089.0,Morning Market Gainers,2015-09-16 09:39:00-04:00,GERN,neutral
543090.0,Benzinga's Top #PreMarket Gainers,2015-09-16 08:10:00-04:00,GERN,positive
543091.0,Geron Announces Start of Janssen Phase 2 Clinical Trial of Imetelstat in Myelofibrosis,2015-09-16 07:32:00-04:00,GERN,neutral
543092.0,Benzinga's Top #PreMarket Gainers,2015-09-14 08:15:00-04:00,GERN,positive
543093.0,Fast Money Traders Share Their Under $5 Stock Picks,2015-09-14 06:56:00-04:00,GERN,positive
543094.0,Morning Market Gainers,2015-09-03 09:42:00-04:00,GERN,neutral
543095.0,Benzinga's Top #PreMarket Gainers,2015-09-03 08:14:00-04:00,GERN,positive
543096.0,UPDATE: Geron +21% Premarket Following Announcement of NEJM Articles Mentioning Transformative Potential of Imetelstat in Hematologic Myeloid Malignancies,2015-09-03 06:13:00-04:00,GERN,neutral
543097.0,Geron +28% After-Hours Following Announcement of New England Journal of Medicine Articles Mentioning Transformative Potential of Imetelstat in Hematologic Myeloid Malignancies,2015-09-02 17:16:00-04:00,GERN,neutral
543098.0,Dual Publications in the New England Journal of Medicine Highlight Transformative Potential of Imetelstat in Hematologic Myeloid Malignancies,2015-09-02 17:03:00-04:00,GERN,positive
543099.0,Option Alert: Geron Jan $4 Call Sweep; 1000 Contracts Above Ask @$0.71,2015-08-06 13:41:00-04:00,GERN,positive
543100.0,Morning Market Losers,2015-08-06 10:01:00-04:00,GERN,negative
543101.0,Benzinga's Top #PreMarket Losers,2015-08-06 08:24:00-04:00,GERN,negative
543102.0,"Geron Reports Inline Q2 Loss $0.06, Sales $251K Vs Est $380K",2015-08-05 17:21:00-04:00,GERN,negative
543103.0,8-K from Geron Shows FDA Granted Orphan Drug Designation for Imetelstat on Jun. 11,2015-06-15 07:10:00-04:00,GERN,positive
543104.0,Shares of Geron Spike Higher as Traders Passing Around FDA Link Showing Orphan Drug Designation for Imetelstat,2015-06-12 09:52:00-04:00,GERN,positive
543105.0,"Geron Reports Inline Q1 EPS -$0.06, Sales $537k Vs Est $330K",2015-04-30 17:03:00-04:00,GERN,neutral
543106.0,Oppenheimer Is Excited About These 3 Biotech Stocks,2015-04-21 08:32:00-04:00,GERN,positive
543107.0,"Oppenheimer Initiates Coverage on Geron at Outperform, Announces $5.50 PT",2015-04-20 16:52:00-04:00,GERN,neutral
543108.0,Benzinga's Top #PreMarket Gainers,2015-03-11 08:08:00-04:00,GERN,positive
543110.0,Geron Shares Now Up 21%; Barron's Article Says Shares Could Hit $6 in a Year,2015-03-05 13:29:00-05:00,GERN,positive
543111.0,"Thursday's Mid-Day Market Movers: Vivint Solar, Alamo Group And More",2015-03-05 13:00:00-05:00,GERN,neutral
543112.0,Geron Reports Q4 EPS $(0.06) vs $0.05,2015-03-03 16:17:00-05:00,GERN,neutral
543113.0,UPDATE: Geron Says Initial Payment of $35M Due,2014-12-16 07:17:00-05:00,GERN,neutral
543114.0,Geron Reports Early HSR Clearance for Global Strategic Collaboration with J&J's Janssen,2014-12-16 07:16:00-05:00,GERN,neutral
543115.0,Morning Market Movers,2014-11-24 09:46:00-05:00,GERN,neutral
543116.0,"Midday Gainers From November 14: Geron, Pandora Media, Bitauto, IAMGOLD",2014-11-14 12:44:00-05:00,GERN,neutral
543117.0,Morning Market Movers,2014-11-14 09:39:00-05:00,GERN,neutral
543118.0,Benzinga's Top #PreMarket Gainers,2014-11-14 08:03:00-05:00,GERN,positive
543119.0,"Stocks To Watch For November 14, 2014",2014-11-14 04:02:00-05:00,GERN,neutral
543120.0,"Shares of Geron Resume, Now Up 30+%",2014-11-13 16:45:00-05:00,GERN,positive
543121.0,"UPDATE: Geron Reports Global Strategic Deal with J&J's Janssen for Development, Commercialization of Imetelstat",2014-11-13 16:18:00-05:00,GERN,neutral
543122.0,"UPDATE: Geron Will Receipt Upfront Payment of $35M, Could Get Added Payments of Up to $900M",2014-11-13 16:16:00-05:00,GERN,neutral
543123.0,"Geron Reports Global Strategic Deal with J&J's Janssen for Development, Commercialization of Imetelstat",2014-11-13 16:16:00-05:00,GERN,neutral
543124.0,Shares of Geron Halted News Pending,2014-11-13 16:13:00-05:00,GERN,positive
543125.0,"Option Alert: GERN Nov 14 $2.5 Put; 10,054 Traded vs 95 OI; Currently $2.63",2014-11-04 10:14:00-05:00,GERN,positive
543126.0,Mid-Afternoon Market Update: Covance Surges After LabCorp Deal; American Realty Capital Shares Slide,2014-11-03 15:11:00-05:00,GERN,positive
543127.0,Mid-Day Market Update: Ford Falls On October Sales Report; Geron Shares Climb,2014-11-03 13:20:00-05:00,GERN,positive
543128.0,"Midday Gainers From November 3: Sapient, Covance, Geron And More",2014-11-03 12:36:00-05:00,GERN,neutral
543129.0,Mid-Morning Market Update: Markets Mixed; Publicis To Acquire Sapient For $3.7 Billion,2014-11-03 11:14:00-05:00,GERN,neutral
543130.0,Morning Market Movers ,2014-11-03 09:38:00-05:00,GERN,neutral
543131.0,Benzinga's Top #PreMarket Gainers,2014-11-03 08:09:00-05:00,GERN,positive
543132.0,UPDATE: Geron Shares Rise 41% Premarket as FDA Removes  Full Clinical Hold on Imetelstat IND,2014-11-03 08:00:00-05:00,GERN,positive
543133.0,UPDATE: Geron Planning Phase 2 Trial Starting 1H of 2015,2014-11-03 07:35:00-05:00,GERN,neutral
543134.0,Geron Announces Removal Of Full Clinical Hold On Imetelstat IND,2014-11-03 07:35:00-05:00,GERN,neutral
543135.0,"Geron Corporation Reports Q3 EPS of $(0.06), Inline; Revenue of $160.0K vs $240.0K Est",2014-11-03 07:32:00-05:00,GERN,neutral
543136.0,"Geron Corporation Reports Q2 EPS of $(0.06), Inline; Revenue of $341.0K vs $210.0K Est",2014-08-11 16:06:00-04:00,GERN,neutral
543137.0,UPDATE: MLV & Co Upgrades Geron After Partial Hold Is Lifted,2014-06-13 08:04:00-04:00,GERN,neutral
543138.0,"MLV & Co. Upgrades Geron Corporation to Buy, Raises PT to $4.25",2014-06-12 15:49:00-04:00,GERN,neutral
543139.0,"Mid-Day Market Movers For Thursday, June 12, 2014",2014-06-12 13:05:00-04:00,GERN,neutral
543140.0,Morning Market Movers ,2014-06-12 09:38:00-04:00,GERN,neutral
543141.0,Benzinga's Top #PreMarket Gainers,2014-06-12 08:03:00-04:00,GERN,positive
543142.0,UPDATE: Geron Shares Rise 30% Premarket as FDA Removes Partial Clinical Hold on Myelofibrosis IST,2014-06-12 07:17:00-04:00,GERN,positive
543143.0,Geron Announces Removal of Partial Clinical Hold on Myelofibrosis IST by FDA,2014-06-12 05:23:00-04:00,GERN,neutral
543144.0,roberto pedone ‏Tweet: This Biotech Stock Could Be the Next Big Short Squeeze $GERN http://www.,2014-06-10 14:46:00-04:00,GERN,neutral
543145.0,Mid-Afternoon Market Update: Markets Trade In Choppy Session As Elizabeth Arden Shares Remain Down,2014-05-13 15:44:00-04:00,GERN,positive
543146.0,Mid-Day Market Update: Rackspace Gains On Upbeat Earnings; DXP Enterprises Shares Slip,2014-05-13 12:40:00-04:00,GERN,positive
543147.0,"Geron Announces May 28, 2014 as Record Date for Distribution of Asterias Series A Common Stock ",2014-05-09 07:32:00-04:00,GERN,neutral
543148.0,Geron to Present at Bank of America Merrill Lynch 2014 Health Care Conference ,2014-05-07 05:27:00-04:00,GERN,positive
543149.0,"Geron Announces Myelofibrosis IST Placed on Partial Clinical Hold, No New Patients Will Be Enrolled Into Trial",2014-03-20 07:33:00-04:00,GERN,negative
543150.0,"Market Wrap For March 12: Nasdaq Ends Losing Streak, Dow Mildly Lower",2014-03-12 16:51:00-04:00,GERN,negative
543151.0,Mid-Afternoon Market Update: Markets Mixed as Geron Shares Take a Beating Following FDA Release,2014-03-12 15:59:00-04:00,GERN,negative
543152.0,"MLV & Co. Downgrades Geron Corporation to Hold, Lowers PT to $2.00",2014-03-12 14:49:00-04:00,GERN,negative
543153.0,Needham Downgrades Geron Corporation to Hold,2014-03-12 13:15:00-04:00,GERN,neutral
543154.0,"Morning Movers for March 12th, 2014",2014-03-12 10:15:00-04:00,GERN,neutral
543155.0,Morning Market Losers ,2014-03-12 09:49:00-04:00,GERN,negative
543156.0,"From Geron Call: FDA concerned about ""persistency"" of lower-grade liver enzyme abnormalities in imetelstat-treated patients.",2014-03-12 08:59:00-04:00,GERN,neutral
543157.0,Geron Conf. Call Related to FDA's Clinical Hold on IMETELSTAT Begins,2014-03-12 08:40:00-04:00,GERN,neutral
543158.0,US Stock Futures Down Ahead Of Federal Budget,2014-03-12 07:32:00-04:00,GERN,neutral
543159.0,UPDATE: Geron Shares Fall 61% Premarket on FDA IND Clinical Hold Notice for Imetelstat ,2014-03-12 07:30:00-04:00,GERN,positive
543160.0,Geron Receives IND Clinical Hold Notice for Imetelstat from FDA,2014-03-12 05:37:00-04:00,GERN,neutral
543161.0,"Earnings Scheduled For March 12, 2014",2014-03-12 05:09:00-04:00,GERN,neutral
543162.0,Geron Shares Moving Higher; May be Attributed to Seeking Alpha Article,2014-02-13 13:26:00-05:00,GERN,positive
543163.0,Geron Corporation Announces Closing of its Public Offering of Common Stock and Exercise of Option to Purchase Additional Shares,2014-02-04 16:01:00-05:00,GERN,positive
543164.0,Geron Prices 22.5M Shares at $4/Share for Gross Proceeds $90M,2014-01-30 09:16:00-05:00,GERN,negative
543165.0,Mid-Afternoon Market Update: Markets Post Rally to Go Into the Green; Precious Metals Take a Hit,2014-01-27 15:32:00-05:00,GERN,positive
543166.0,Mid-Day Market Update: U.S. Stocks Tumble; Regis Shares Decline On Downbeat Results,2014-01-27 12:28:00-05:00,GERN,positive
543167.0,Morning Market Losers ,2014-01-27 10:33:00-05:00,GERN,negative
543168.0,Mid-Morning Market Update: Markets Mostly Higher; Caterpillar Results Beat Street View,2014-01-27 10:23:00-05:00,GERN,neutral
543169.0,Benzinga's Top #PreMarket Losers,2014-01-27 08:20:00-05:00,GERN,negative
543170.0,Geron Reports 20 Patients have Discontinued from Imetelstat Study Since its Inception -8K,2014-01-27 08:20:00-05:00,GERN,neutral
543171.0,Market Wrap For December 10: Fed Meeting One Week Away,2013-12-10 16:41:00-05:00,GERN,neutral
543172.0,Mid-Morning Market Update: Markets Edge Lower; Toll Brothers Profit Tops Estimates,2013-12-10 10:53:00-05:00,GERN,positive
543173.0,Benzinga's Top #PreMarket Gainers,2013-12-10 08:11:00-05:00,GERN,positive
543174.0,Benzinga's Top Upgrades,2013-12-10 08:00:00-05:00,GERN,positive
543175.0,"Needham Upgrades Geron Corporation to Buy, Announces $10.00 PT",2013-12-10 07:54:00-05:00,GERN,neutral
543176.0,"Geron Shares Rise 12% Pre-Market, Following Company's Monday Presentation at ASH",2013-12-10 07:52:00-05:00,GERN,positive
543177.0,Geron Shares Rise 15% After-Hours During Company's Presentation at ASH,2013-12-09 18:08:00-05:00,GERN,positive
543178.0,Geron Spikes Higher,2013-12-09 17:57:00-05:00,GERN,neutral
543179.0,Mid-Day Market Update: Ulta Salon Tumbles On Downbeat Results; Finisar Shares Rise,2013-12-06 12:36:00-05:00,GERN,positive
543180.0,Mid-Morning Market Update: Markets Surge; American Eagle Issues Downbeat Profit Forecast,2013-12-06 10:23:00-05:00,GERN,positive
543181.0,"Option Alert: Geron March $8 Call; 5,000 Contract Trade at Ask @$0.80; Currently $5.86 ",2013-12-06 10:23:00-05:00,GERN,positive
543182.0,Benzinga's Top #PreMarket Gainers,2013-12-06 08:25:00-05:00,GERN,positive
543183.0,Geron Shares Rise 26% Pre-Market on Report Released by Mayo Clinic on Imetelstat,2013-12-06 07:17:00-05:00,GERN,positive
543184.0,Bloomberg First Word Reporting Geron Has Pulled its Planned Imetelstat Study,2013-11-26 14:09:00-05:00,GERN,neutral
543185.0,Market Wrap For November 7: Markets Take A Breather As Twitter Takes Center Stage,2013-11-07 16:42:00-05:00,GERN,neutral
543186.0,"Geron Corporation Reports Q3 EPS of $(0.06), Inline; Revenue of $181.0K vs $410.0K Est",2013-11-07 16:11:00-05:00,GERN,neutral
543187.0,Hearing Positive Morgan Stanley Comments on Geron,2013-11-07 13:27:00-05:00,GERN,positive
543188.0,Geron Revealed Positive Imetelstat Results Amidst Data Concerns,2013-11-07 13:10:00-05:00,GERN,positive
543189.0,Stifel Nicolaus Upgrades Geron Corporation to Hold,2013-11-07 11:54:00-05:00,GERN,neutral
543190.0,"Option Alert: Geron Call Volume at 753% of Average on Adam F Article and Ahead of Earnings After Close, Currently $6.16",2013-11-07 11:29:00-05:00,GERN,positive
543191.0,Hearing Wells Fargo Negative Comments on Geron Imetelstat Data,2013-11-07 10:41:00-05:00,GERN,negative
543192.0,"TheStreet.com's Adam Feuerstein Publishes: 'Geron's Imetelstat Data in Myelofibrosis: 4 CRs, 1 PR'",2013-11-07 09:14:00-05:00,GERN,neutral
543193.0,Geron Spikes Higher,2013-11-07 09:09:00-05:00,GERN,neutral
543194.0,"Geron (Nasdaq: GERN) Shares Skyrocket, Coverage Initiated with a Buy",2013-10-17 09:13:00-04:00,GERN,positive
543195.0,"Stocks to Watch for October 16, 2013",2013-10-16 16:54:00-04:00,GERN,neutral
543196.0,"Option Alert: Geron November 4 Put; 5,000 Contracts Traded @$0.50; Currently $4.17",2013-10-16 12:14:00-04:00,GERN,positive
543197.0,"McNicoll Lewis Vlak Initiates Coverage on Geron Corporation at Buy, Announces $6.50 PT",2013-10-15 16:35:00-04:00,GERN,neutral
543198.0,"MLV & Co. Initiates Coverage on Geron Corporation at Buy, Announces $6.50 PT",2013-10-15 16:23:00-04:00,GERN,neutral
543199.0,Geron Data from Myelofibrosis IST to be Presented at ASH Oral Session on December 9 -8K,2013-10-15 06:47:00-04:00,GERN,neutral
543200.0,Morning Market Movers ,2013-09-23 10:09:00-04:00,GERN,neutral
543201.0,UPDATE: Piper Jaffray Upgrades Geron on Enhanced Imetelstat Confidence,2013-08-09 08:18:00-04:00,GERN,positive
543202.0,"Piper Jaffray Upgrades Geron Corporation to Overweight, Raises PT to $4.00",2013-08-09 06:37:00-04:00,GERN,negative
543203.0,Geron Corporation Reports Q2 EPS of $(0.70) vs $(0.07) Est,2013-08-08 16:06:00-04:00,GERN,neutral
543204.0,Geron Presents Updated Results from Imetelstat Phase 2 Proof-of-Concept Trial in Essential Thrombocythemia,2013-06-16 19:06:00-04:00,GERN,neutral
543205.0,Geron Corporation Reports Q1 EPS of $(0.09) vs $(0.08) Est; Revenue of $765.0K vs $710.0K Est,2013-04-25 17:05:00-04:00,GERN,neutral
543206.0,UPDATE: Piper Jaffray Downgrades Geron Corporation to Neutral on Possible Safety Red Flags,2013-03-14 07:32:00-04:00,GERN,positive
543207.0,"Piper Jaffray Downgrades Geron Corporation to Neutral, Lowers PT to $1.50",2013-03-14 06:27:00-04:00,GERN,negative
543208.0,UPDATE: Stifel Downgrades Geron from Hold to Sell,2013-03-13 14:29:00-04:00,GERN,neutral
543209.0,Stifel's Brian Klein Confirms Downgraded Geron to Sell Midday,2013-03-13 13:41:00-04:00,GERN,neutral
543210.0,"Geron Shares Falling Below $1.35, Hearing Analyst Downgrade",2013-03-13 13:35:00-04:00,GERN,positive
543211.0,Geron Corporation Reports Q4 EPS of $(0.12) vs $(0.14) Est,2013-03-12 16:35:00-04:00,GERN,neutral
543212.0,"Earnings Scheduled For March 12, 2013",2013-03-12 04:41:00-04:00,GERN,neutral
543213.0,UPDATE: Piper Jaffray Initiates Geron Corporation at Overweight on Risk/Reward  ,2013-01-18 08:10:00-05:00,GERN,negative
543214.0,"Piper Jaffray Initiates Coverage on Geron Corporation at Overweight, Announces $3.00 PT",2013-01-17 16:10:00-05:00,GERN,negative
543215.0,BioTime to Buy Human Embryonic Stem Cell Program Assets of Geron,2013-01-07 07:41:00-05:00,GERN,positive
543216.0,"Top Narrow Based Indexes For December 17, 2012",2012-12-17 14:13:00-05:00,GERN,positive
543217.0,"Benzinga's Small Cap Movers for Monday December 10, 2012",2012-12-10 20:13:00-05:00,GERN,neutral
543218.0,Morning Market Movers,2012-12-10 09:54:00-05:00,GERN,neutral
543219.0,Geron Shares Rally Following Positive Results from Phase 2 Study of Imetelstat,2012-12-10 08:06:00-05:00,GERN,positive
543220.0,"Geron, Angiochem Enter License Pact",2012-12-06 17:21:00-05:00,GERN,neutral
543221.0,Mid-Day Market Update: Markets Flat Following Obama Interview,2012-12-04 14:27:00-05:00,GERN,neutral
543222.0,Stocks Hitting 52-Week Lows,2012-12-04 10:13:00-05:00,GERN,negative
543223.0,Morning Market Losers,2012-12-04 09:53:00-05:00,GERN,negative
543224.0,Benzinga's Top Pre-Market Losers,2012-12-04 08:20:00-05:00,GERN,negative
543225.0,US Stock Futures Edge Up; Euro Rises Against Dollar,2012-12-04 06:11:00-05:00,GERN,neutral
543226.0,"Stocks To Watch For December 4, 2012",2012-12-04 02:49:00-05:00,GERN,neutral
543227.0,UPDATE: Geron Down ~20% from Close,2012-12-03 16:35:00-05:00,GERN,neutral
543228.0,Geron Corporation Resumes Trading,2012-12-03 16:35:00-05:00,GERN,neutral
543229.0,PREVIEW: Geron Corporation to Resume Trading at 4:35 PM,2012-12-03 16:15:00-05:00,GERN,neutral
543230.0,Geron to Resume at 4:35PM EST,2012-12-03 16:10:00-05:00,GERN,neutral
543231.0,Geron to Discontinue Development of GRN1005; to Cut 64 Full-Time Positions,2012-12-03 16:08:00-05:00,GERN,negative
543232.0,Geron Halted News Pending,2012-12-03 16:01:00-05:00,GERN,neutral
543233.0,Geron Resumes Trading,2012-11-15 16:45:00-05:00,GERN,neutral
543234.0,PREVIEW: Geron to Resume Trading at 4:45pm,2012-11-15 16:24:00-05:00,GERN,neutral
543235.0,"UPDATE: BioTime, Geron Enter Deal on Stem Cell Assets",2012-11-15 16:22:00-05:00,GERN,positive
543236.0,"Biotime In Pact w/ Geron for Stem Cell Assets, Biotime to Contribute $5M Cash, $30M Shares",2012-11-15 16:16:00-05:00,GERN,positive
543237.0,Geron Trading Halted News Pending,2012-11-15 16:12:00-05:00,GERN,neutral
543238.0,Geron Reports Q3 EPS $-0.13 vs $-0.14 Est; Revenues $636K vs $380.00K Est,2012-10-30 16:24:00-04:00,GERN,neutral
543239.0,Geron Acknowledges Letter to its Stockholders from BioTime,2012-10-19 07:36:00-04:00,GERN,neutral
543240.0,Geron Files Prospectus; Will Offer $150M Shares on Warrant,2012-10-11 17:26:00-04:00,GERN,positive
543241.0,Geron Will Sell Up to $50M of Stock with MLV as Sales Agent,2012-10-09 16:35:00-04:00,GERN,neutral
543242.0,Geron Appoints Susan Molineaux and Daniel Bradbury to Board of Directors,2012-09-28 07:33:00-04:00,GERN,neutral
543243.0,Morning Market Losers,2012-09-10 09:55:00-04:00,GERN,negative
543244.0,Benzinga's Top Pre-Market Losers,2012-09-10 08:17:00-04:00,GERN,negative
543245.0,UPDATE: Geron Falls Almost 50% on Phase 2 Halt,2012-09-10 08:14:00-04:00,GERN,neutral
543246.0,Geron Corporation Resumes Trading,2012-09-10 08:00:00-04:00,GERN,neutral
543247.0,EPD Announces Launch of Second 300MMCF/D Train,2012-09-10 07:37:00-04:00,GERN,neutral
543248.0,Geron Corporation to Resume Trading at 8:00am,2012-09-10 07:34:00-04:00,GERN,neutral
543249.0,Geron Discontinues Phase 2 Imetelstat Study ,2012-09-10 07:33:00-04:00,GERN,neutral
543250.0,Geron Corporation Halted,2012-09-10 07:32:00-04:00,GERN,neutral
543251.0,Geron Announces it Will Discontinue Phase II Study of Imetelstat,2012-09-10 07:32:00-04:00,GERN,neutral
543252.0,JMP Securities Initiates Coverage on Geron at Market Perform,2012-09-06 10:21:00-04:00,GERN,positive
543253.0,"Benzinga's Microcap Movers for Thursday August 30, 2012",2012-08-30 17:49:00-04:00,GERN,neutral
543254.0,UPDATE: Stifel Nicolaus Initiates Geron Corporation at Buy with $4 PT; Oncology Refocus Paying Off  ,2012-08-30 12:59:00-04:00,GERN,neutral
543255.0,"Stifel Nicolaus Initiates Coverage on Geron at Buy, Announces PT of $4",2012-08-30 08:03:00-04:00,GERN,neutral
543256.0,Federal Appeals Court Says Funding of Embryonic Stem Cell Research Can Continue,2012-08-24 11:59:00-04:00,GERN,neutral
543257.0,Geron Reports Q1 EPS $-0.15 vs $-0.18 Est; Revenues $1.3M vs $490.00K Est,2012-05-02 16:40:00-04:00,GERN,neutral
543258.0,Geron Trading 6.6% Higher on Heavy Volume; Currently at $1.62,2012-04-10 09:53:00-04:00,GERN,neutral
543259.0,Geron Corporation Awarded Patent for Brain Tumor Device,2012-04-10 09:53:00-04:00,GERN,neutral
543260.0,Notable Call Options Activity in Geron,2012-03-20 11:43:00-04:00,GERN,neutral
543261.0,Notable Put Options Activity in Geron,2012-01-17 11:33:00-05:00,GERN,neutral
543262.0,Geron Trading 4% Higher on Heavy Volume; Currently at $1.8,2012-01-11 13:00:00-05:00,GERN,neutral
543263.0,Geron CEO Says Actively Talking to Sell Stem Cell Assets,2012-01-11 13:00:00-05:00,GERN,positive
543264.0,Geron Corp Announces Phase 2 Data on Imetelstat Cancer Drug Won't be out Until Q4 2012 -Presentation Slides,2012-01-11 11:12:00-05:00,GERN,negative
543265.0,FDA Warns About Unproven Stem Cell Claims,2012-01-08 19:11:00-05:00,GERN,negative
543266.0,Geron Corporation Appoints Graham Cooper as Chief Financial Officer,2012-01-05 16:31:00-05:00,GERN,neutral
543267.0,Geron Shares Rise 13% Pre-Market; May be Attributed to Positive Seeking Alpha Article,2011-12-27 08:45:00-05:00,GERN,positive
543268.0,Geron Initiates Phase 2 Trial of GRN1005 in Brain Metastases From Breast Cancer   ,2011-12-12 07:30:00-05:00,GERN,negative
543269.0,"End-of-Day Market Summary for November 16, 2011",2011-11-16 16:15:00-05:00,GERN,neutral
543270.0,"J.P. Morgan Downgrades Geron, Removes 2012 PT",2011-11-16 07:48:00-05:00,GERN,neutral
543271.0,"Financial Breakfast: Morning News Summary for November 16, 2011",2011-11-16 07:42:00-05:00,GERN,neutral
543272.0,JP Morgan Downgrades Geron to Neutral,2011-11-16 06:30:00-05:00,GERN,positive
543273.0,Even as Geron Shares Drop Other Players Converge on Stem Cells Space,2011-11-15 12:37:00-05:00,GERN,neutral
543274.0,Geron Presents Final Phase 1 Clinical Data on GRN1005 at AACR-NCI-EORTC   ,2011-11-15 07:30:00-05:00,GERN,neutral
543275.0,Geron Resumes Trading,2011-11-14 16:30:00-05:00,GERN,neutral
543276.0,Geron to Resume Trading at 4:30pm,2011-11-14 16:10:00-05:00,GERN,neutral
543277.0,"Geron Will Cut 66 Jobs; Discontinue Development of Stem Cell Programs; Guides Cash Spending $5M in Q4, $3 in H1 of 2012",2011-11-14 16:07:00-05:00,GERN,negative
543278.0,Geron to Focus on Its Novel Cancer Programs,2011-11-14 16:06:00-05:00,GERN,negative
543279.0,Geron Halted; Pending News,2011-11-14 16:02:00-05:00,GERN,neutral
543280.0,UPDATE: Rodman & Renshaw Lowers PT to $4 on Geron ,2011-11-09 10:08:00-05:00,GERN,negative
543281.0,Rodman & Renshaw Lowers PT on Geron to $4,2011-11-09 09:06:00-05:00,GERN,negative
543282.0,Geron Corporation Appoints John A. Scarlett as Chief Executive Officer and Director   ,2011-09-29 17:02:00-04:00,GERN,neutral
543283.0,Notable Call Options Activity in Geron,2011-09-01 12:25:00-04:00,GERN,neutral
543284.0,Stocks to Watch for Wednesday 8/03/2011: Fresh 52 Week Highs and Lows,2011-08-03 01:05:00-04:00,GERN,positive
543285.0,Stocks to Watch for Tuesday 8/02/2011: Fresh 52-Week Highs and Lows,2011-08-02 04:20:00-04:00,GERN,positive
543286.0,Geron Corp. Reports Q2 EPS $(0.17) vs $(0.17) Est; Revenues $21.9M vs Low-Number Analyst Estimate of $1.37M,2011-07-28 16:32:00-04:00,GERN,neutral
543287.0,Benzinga's Top Pre-Market NASDAQ Gainers,2011-07-08 08:18:00-04:00,GERN,positive
543288.0,"Mad Money Lightning Round: Cramer Likes Schlumberger, Oracle",2011-06-28 01:02:00-04:00,GERN,negative
543289.0,Stocks to Watch for 6/21/11: Fresh 52 Week Highs and Lows,2011-06-21 04:09:00-04:00,GERN,positive
543290.0,Stocks to Watch for 6/20/11: Fresh 52-Week Highs and Lows,2011-06-20 04:13:00-04:00,GERN,positive
543291.0,Stocks to Watch for 6/16/11: Fresh 52-Week Highs and Lows,2011-06-16 02:28:00-04:00,GERN,positive
543292.0,"Geron Presents Data from GRNOPC1 Trial at International Conferences, Recieves Clearance from FDA to Expand Eligibility Criteria",2011-06-07 07:38:00-04:00,GERN,positive
543293.0,Options Brief: Geron Corporation,2011-05-24 13:29:00-04:00,GERN,neutral
543294.0,Geron Statement Regarding European Cancer Vaccine Patents   ,2011-05-09 12:31:00-04:00,GERN,negative
543295.0,"Hearing US Appeals Court Overturns Ban on Stem-Cell Funding (GERN, STEM) ",2011-04-29 11:08:00-04:00,GERN,negative
543296.0,Geron Corp Ticks Higher On Patient News (GERN),2011-04-07 09:47:00-04:00,GERN,neutral
543297.0,Geron Announces Preclinical Study Data of GRNCM1   ,2011-03-01 07:41:00-05:00,GERN,neutral
543298.0,"Geron Appoints David Greenwood President, Interim CEO",2011-02-09 09:03:00-05:00,GERN,neutral
543299.0,"Benzinga's Top Pre-Market NASDAQ Gainers (DEPO, NPSP, GERN, XNPT)",2011-01-31 08:20:00-05:00,GERN,positive
543300.0,"Mad Money Lightning Round OT: Cramer Is A Seller of Quantum Corporation (QTM) (ASH, QTM, GERN, CRM, NFLX)",2011-01-26 19:36:00-05:00,GERN,negative
543301.0,A Peek Into The Market Before The Trading Starts,2011-01-10 07:52:00-05:00,GERN,neutral
543302.0,Geron Announces Publication Demonstrating Activity of Imetelstat   ,2011-01-10 07:38:00-05:00,GERN,neutral
543303.0,Geron Corporation Announces Closing of Its Public Offering of Common Stock,2010-12-10 16:03:00-05:00,GERN,neutral
543304.0,Cephalon in Stem Cell Deal - Analyst Blog,2010-12-09 11:03:00-05:00,GERN,neutral
543305.0,Cephalon in Stem Cell Deal - Analyst Blog,2010-12-09 10:17:00-05:00,GERN,neutral
543306.0,EPIC! FDA OKs Human Clinical Trials of Embryonic Stem Cell Therapy; Trials Now Underway,2010-12-09 09:19:00-05:00,GERN,neutral
543307.0,Geron Corporation Underwriters Purchase 2.6M Shares,2010-12-08 16:29:00-05:00,GERN,positive
543308.0,Market Roundup,2010-12-07 12:38:00-05:00,GERN,neutral
543309.0,Geron's Pipeline Progresses  - Analyst Blog,2010-12-07 11:00:00-05:00,GERN,neutral
543310.0,Geron's Pipeline Progresses  - Analyst Blog,2010-12-07 10:18:00-05:00,GERN,neutral
543311.0,"Benzinga's Top Pre-Market NASDAQ Losers (GERN, AVGO, CELG, RIMM)",2010-12-07 09:38:00-05:00,GERN,negative
543312.0,Geron Corporation Offering 17.4 Million Shares at $5.00/share,2010-12-07 09:35:00-05:00,GERN,positive
543313.0,Geron Corporation Prices Public Offering at $5 per Share,2010-12-07 09:02:00-05:00,GERN,positive
543314.0,"Citigroup, Geron: After-Hours Trading",2010-12-06 20:42:00-05:00,GERN,neutral
543315.0,Geron Corporation Announces Public Offering,2010-12-06 16:05:00-05:00,GERN,neutral
543316.0,Lessons From A Losing Biotech Portfolio,2010-11-29 10:15:00-05:00,GERN,negative
543317.0,Geron Misses Zacks Ests.  - Analyst Blog,2010-11-02 13:54:00-04:00,GERN,negative
543318.0,Geron Corporation Posts Mixed Results; Receives First Milestone Payment (GERN),2010-10-28 16:58:00-04:00,GERN,neutral
543319.0,Geron Corporation Reports 2010 Third Quarter Financial Results and Events - Loss of $0.19 Per Share,2010-10-28 16:41:00-04:00,GERN,neutral
543320.0,"Benzinga's Top Pre-Market NASDAQ Gainers (ACTI, GERN, TQNT, CCME)",2010-10-12 08:16:00-04:00,GERN,positive
543321.0,First US Trial of Embryonic Stem Cells in Humans,2010-10-11 15:20:00-04:00,GERN,neutral
543322.0,"Betting on Biotech - Interview with Adam Feuerstein, Senior Columnist and Biotech Analyst of TheStreet.com",2010-10-01 12:46:00-04:00,GERN,neutral
543323.0,"Benzinga's Top Pre-Market NASDAQ Gainers (SGEN, CADC, GERN, CRUS) ",2010-09-29 08:53:00-04:00,GERN,positive
543324.0,"Benzinga's Top Pre-Market NASDAQ Gainers (GERN, ARMH, BRCD, CASY) ",2010-09-09 08:51:00-04:00,GERN,positive
543325.0,"Benzinga’s Top Pre-Market NASDAQ Losers (CRUS, ASML, GERN, COCO)",2010-08-24 08:51:00-04:00,GERN,negative
543326.0,Geron Posts Narrower Loss - Analyst Blog,2010-08-03 12:06:00-04:00,GERN,negative
543327.0,Call Volume Grows on Geron (GERN),2010-08-02 12:50:00-04:00,GERN,neutral
543328.0,"Benzinga’s Top Pre-Market NASDAQ Gainers (FSII, GERN, ATPG, CRUS)",2010-08-02 09:21:00-04:00,GERN,positive
543329.0,July Impressive -- S&Ps Up 6.9%  07-30-2010,2010-07-30 19:07:00-04:00,GERN,positive
543330.0,"Top Narrow Based Indexes for July 30 (ECPG, GERN, PTIE)",2010-07-30 14:10:00-04:00,GERN,positive
543331.0,"News Summary (GERN, BAIRY)",2010-07-30 13:17:00-04:00,GERN,neutral
543332.0,Calls Sold on Geron Corp. (GERN),2010-07-30 10:30:00-04:00,GERN,neutral
543333.0,"Benzinga’s Top Pre-Market NASDAQ Gainers (PWER, GERN, OREX, NFLX)",2010-07-30 08:54:00-04:00,GERN,positive
543334.0,Geron to Proceed with First Human Clinical Trial of Embryonic Stem Cell-Based Therapy,2010-07-30 08:35:00-04:00,GERN,neutral
543335.0,Geron Corporation Reports Second Quarter Financial Results and Events,2010-07-29 16:46:00-04:00,GERN,neutral
543336.0,Calls Purchased on Geron Corp. (GERN),2010-07-19 13:43:00-04:00,GERN,neutral
543337.0,Geron Initiates Randomized Phase 2 Clinical Trial Of Imetelstat In Non-Small Cell Lung Cancer (GERN),2010-07-19 07:58:00-04:00,GERN,negative
543338.0,"Top Day Trader Alerts (BPAX, CNTF, GERN, HAUP, NTES, GOLD, SIRI)",2010-05-20 08:49:00-04:00,GERN,positive
543339.0,"Benzinga’s Top Pre-Market Gainers (GERN, MSPD, ENG, QGEN, ASML)",2010-05-19 10:00:00-04:00,GERN,positive
543340.0,"Top Day Trader Alerts (ABK, IMOS, DE, GERN, HAUP)",2010-05-19 08:52:00-04:00,GERN,positive
543341.0,The Twitter-24/7 Wall St. Stock Market Report 5.19 The Wisdom Of Crowds?,2010-05-19 08:45:00-04:00,GERN,positive
543342.0,"Top 10 Analyst Upgrades and Downgrades (BP, SCHW, CCRT, LTD, MCK, MUSA, NTES, PT, VIP, WPI)",2010-05-19 08:30:00-04:00,GERN,positive
543343.0,How Will Obama-Care Play Into The Markets And ETFs?,2010-03-21 21:50:00-04:00,GERN,positive
543344.0,"Benzinga’s Top Pre-Market Gainers (STP, URBN, PETM, GERN, SIGM)",2010-03-04 08:25:00-05:00,GERN,positive
543345.0,"Benzinga’s News Roundup (JPM, CRI, BCRX, GERN, ALNY, JEC)",2010-01-15 08:05:00-05:00,GERN,neutral
543346.0,"Benzinga’s Top Pre- Market Losers (AUXL, GIII, EZCH, ASFI, GERN, AMED)",2009-12-16 09:21:00-05:00,GERN,negative
543347.0,"Benzinga’s Top Pre- Market Gainers (CAMD, CLDX, JAVA, SONS, TSTC, GERN, ARMH)",2009-12-14 08:57:00-05:00,GERN,positive
543348.0,"Benzinga’s Top Pre- Market Gainers (ZILG, YONG, GERN, ARIA, XLNX) ",2009-12-08 08:42:00-05:00,GERN,positive
543349.0,Stem Cell Research Company Stocks On the Move,2009-12-02 16:11:00-05:00,GERN,neutral
543350.0,"STEM, GERN and ASTM shares seeing unusual movement following the NIH Announcement",2009-12-02 14:01:00-05:00,GERN,positive
543351.0,"Benzinga’s Top Pre- Market Gainers (PRGX, ENZN, NTAP, SHLD, GERN, SVA, SOLF)",2009-11-19 08:52:00-05:00,GERN,positive
543352.0,Geron and FDA Reach Agreement on Clinical Hold,2009-10-30 12:33:00-04:00,GERN,positive
543353.0,Geron (GERN) Stocks Not A Good Short-Term Buy,2009-10-15 06:38:00-04:00,GERN,negative
543354.0,"Cramer Says Buy Citigroup, GILD, ETP, CELG and sell ANN, GERN",2009-10-02 06:21:00-04:00,GERN,neutral
543355.0,"RothmanResearch.com Stock Review for FNSR, PLCM, LOGI, PSYS, GERN and MPEL",2009-08-18 06:49:00-04:00,GERN,neutral
